Rajkuberan Chandrasekaran
Overview
Explore the profile of Rajkuberan Chandrasekaran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
87
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chandrasekaran R, Joseph J
Int Immunopharmacol
. 2025 Feb;
150:114257.
PMID: 39966034
No abstract available.
2.
Palani S, Joseph J, Sridhar P, Bupesh G, Saravanan K, Chandrasekaran R
Mol Biotechnol
. 2024 Dec;
PMID: 39704751
The current study examines the anticancer properties of the chemical carthamidin in breast cancer through in-vitro and in silico analysis. This study's results demonstrated that carthamidin strongly inhibited the proliferation...
3.
Natarajan K, Chandrasekaran R, Sundararaj R, Joseph J, Asaithambi K
Neurochem Res
. 2024 Dec;
50(1):54.
PMID: 39661296
The cognitive dysfunction in the brain cause severe pathological consequences such as Alzheimer's disease (AD), Parkinson's disease. The current treatments are cost expensive and also cause negative side effects. Therefore...
4.
Chandrasekaran R, Krishnan M, Chacko S, Gawade O, Hasan S, Joseph J, et al.
Front Oncol
. 2023 Dec;
13:1322875.
PMID: 38125945
Introduction: Early-life osteosarcoma is associated with severe morbidity and mortality, particularly affecting young children and adults. The present cancer treatment regimen is exceedingly costly, and medications like ifosfamide, doxorubicin, and...
5.
Chandrasekaran R, Patil S, Krishnan M, Kuca K
Mini Rev Med Chem
. 2022 Dec;
23(9):1058-1069.
PMID: 36515021
In the current epoch, noble metals/metal oxides with precise structures are needed to develop sustainable products to improve the welfare of human beings and the environment. Nanomaterials in the regime...
6.
Kumar Seetharaman P, Chandrasekaran R, Periakaruppan R, Gnanasekar S, Sivaperumal S, Abd-Elsalam K, et al.
Biology (Basel)
. 2021 Jun;
10(6).
PMID: 34071886
To develop a benign nanomaterial from biogenic sources, we have attempted to formulate and fabricate silver nanoparticles synthesized from the culture filtrate of an endophytic fungus strain LA-1 (PoAgNPs). The...
7.
Patil S, Chandrasekaran R
J Genet Eng Biotechnol
. 2020 Oct;
18(1):67.
PMID: 33104931
Background: Translating the conventional scientific concepts into a new robust invention is a much needed one at a present scenario to develop some novel materials with intriguing properties. Particles in...
8.
Sangilimuthu A, Sivaraman T, Chandrasekaran R, Sundaram K, Ekambaram G
J Complement Integr Med
. 2020 Aug;
18(1):51-57.
PMID: 32745070
Objectives: Aqueous leaves extracts of and were prepared and effect of the extracts on inhibiting alpha-amylase playing essential roles on converting starch into glucose have been examined using assays. Methods:...
9.
Chandrasekaran R, Seetharaman P, Krishnan M, Gnanasekar S, Sivaperumal S
3 Biotech
. 2018 Feb;
8(2):83.
PMID: 29430347
This study manifests the larvicidal efficacy of latex extract and silver nanoparticles (CPAgNPs) synthesized using latex, against developing immature juveniles of and . Briefly, the latex was collected and fractioned...
10.
Seetharaman P, Gnanasekar S, Chandrasekaran R, Chandrakasan G, Syed A, Hodhod M, et al.
Environ Sci Pollut Res Int
. 2017 Jul;
24(26):21272-21282.
PMID: 28741206
Upon screening for novel and potential biocompounds with larvicidal activities, we successfully isolated hamisonine (HMSN) a limonoid compound from endophytic fungi Penicillium oxalicum LA-1 of Limonia acidissima. The extracted compound...